• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    More On ONCY

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials


    Oncolytics Biotech Inc. (ONCY)

    -NasdaqCM
    0.55 0.04(6.90%) Dec 19, 3:59PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development17,417  31,538  22,968  
    Selling General and Administrative5,075  5,308  5,239  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (22,493) (36,846) (28,206)
    Income from Continuing Operations
    Total Other Income/Expenses Net350  346  (278)
    Earnings Before Interest And Taxes(22,143)(36,500)(28,485)
    Interest Expense -   -   -  
    Income Before Tax(22,143)(36,500)(28,485)
    Income Tax Expense5  31  39  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(22,148)(36,531)(28,524)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (22,148) (36,531) (28,524)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (22,148) (36,531) (28,524)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.